Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy

Richard D. Redvanly; Judith L. Chezmar; Robert M. Strauss; John R. Galloway; Thomas D. Boyer; Michael E. Bernardino

doi:10.1148/radiology.188.1.8390070

Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy

Richard D. Redvanly, Judith L. Chezmar, Robert M. Strauss, John R. Galloway, Thomas D. Boyer, Michael E. Bernardino

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Abstract

The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

Original language	English (US)
Pages (from-to)	283-285
Number of pages	3
Journal	Radiology
Volume	188
Issue number	1
DOIs	https://doi.org/10.1148/radiology.188.1.8390070
State	Published - Jul 1993
Externally published	Yes

Keywords

Alcohol, 761.1269
Liver neoplasms, therapy, 761.1269, 761.323
Liver, interventional procedures, 761.1269

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1148/radiology.188.1.8390070

Cite this

@article{2237d735357c498fad17aaa6d723abfc,

title = "Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy",

abstract = "The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.",

keywords = "Alcohol, 761.1269, Liver neoplasms, therapy, 761.1269, 761.323, Liver, interventional procedures, 761.1269",

author = "Redvanly, {Richard D.} and Chezmar, {Judith L.} and Strauss, {Robert M.} and Galloway, {John R.} and Boyer, {Thomas D.} and Bernardino, {Michael E.}",

year = "1993",

month = jul,

doi = "10.1148/radiology.188.1.8390070",

language = "English (US)",

volume = "188",

pages = "283--285",

journal = "Radiology",

issn = "0033-8419",

publisher = "Radiological Society of North America Inc.",

number = "1",

}

TY - JOUR

T1 - Malignant hepatic tumors

T2 - Safety of high-dose percutaneous ethanol ablation therapy

AU - Redvanly, Richard D.

AU - Chezmar, Judith L.

AU - Strauss, Robert M.

AU - Galloway, John R.

AU - Boyer, Thomas D.

AU - Bernardino, Michael E.

PY - 1993/7

Y1 - 1993/7

N2 - The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

AB - The authors retrospectively analyzed clinical records to determine the safety and complication rate of percutaneous ethanol ablation therapy with more than 10 mL of ethanol administered per session for treatment of malignant hepatic tumors. Ten patients underwent a total of 35 sessions with 10 mL or more of ethanol, and four underwent 18 sessions with 10 mL or less. No serious complications occurred with any dose. Pain and fever were the most common complications at all doses, and the higher frequency of these at larger ethanol volumes may be related to the greater degree of tumor necrosis induced by the larger volume.

KW - Alcohol, 761.1269

KW - Liver neoplasms, therapy, 761.1269, 761.323

KW - Liver, interventional procedures, 761.1269

UR - http://www.scopus.com/inward/record.url?scp=0027258795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027258795&partnerID=8YFLogxK

U2 - 10.1148/radiology.188.1.8390070

DO - 10.1148/radiology.188.1.8390070

M3 - Article

C2 - 8390070

SN - 0033-8419

VL - 188

SP - 283

EP - 285

JO - Radiology

JF - Radiology

IS - 1

ER -

Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this